approval in November
serves on advisory boards of Sanofi Aventis and Merck Sharp & Dohme (all honoraria paid to employer)
Gutzwiller JP, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M, Gutmann H, Drewe J, Henzen C, Goeke B, Beglinger C: Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
The distinction is clinically important: if you experience nausea, vomiting, or abdominal discomfort, these are recognized tirzepatide-related effects that may improve with time or dose adjustment
If you take other diabetes medications, particularly insulin or sulfonylureas, there is an increased risk of hypoglycaemia